KIF1A and peripheral neuropathy: Non-sense mutations which can lead to complete loss of functionality of the protein can cause significant clinical manifestations in the peripheral nervous system (PNS), as peripheral neuropathy is common in more than 60% of the SPG30 patients [22,70,71].